Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 27 April 1984:
Vol. 224. no. 4647, pp. 357 - 363
DOI: 10.1126/science.6584975
Prev | Table of Contents | Next

Articles

Science, Vol 224, Issue 4647, 357-363
Copyright © 1984 by American Association for the Advancement of Science

articles

Biotechnology as an intellectual property

RG Adler

Recent advances in biotechnology have created many public policy and legal issues, one of the most significant of which is the treatment of biotechnological industrial products, particularly under the patent system. Patents represent one of several types of intellectual property; their ownership confers the right to exclude others from benefitting from the tangible products of a proprietary subject matter. Intellectual property law and its protections will play a major role in the rate at which biotechnology develops in the United States. In this article biotechnological intellectual property issues are reviewed in the context of their underlying legal requirements. The implications of other factors, such as international competition, research funding, and gene ownership, are also considered.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Genome research: fulfilling the public's expectations for knowledge and commercialization.
R. Adler (1992)
Science 257, 908-914
   Abstract »    PDF »
The Social Context of Policy Research.
G. L. ALBRECHT and D. J. JACKSON (1985)
Sociological Methods Research 13, 275-287


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)